Trial Profile
Safety and efficacy of pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jun 2017
Price :
$35
*
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Bone cancer; Sarcoma; Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 12 Jun 2017 New trial record
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology